11Mar 2025
ETI Therapy Improves CRS Symptoms in Children with Cystic Fibrosis

ETI Therapy Improves CRS Symptoms in Children with Cystic Fibrosis

ETI enhances sinonasal health and quality of life in CF youth. The MODUL-CF study (391 participants) assessed ETI therapy’s impact on CRS symptoms in children with cystic fibrosis. Significant improvements in SN-5 scores were seen within 1 month and sustained for 12 months. Sinus CT scores (LMKS) also improved in 43 patients. These findings highlight ETI’s benefits beyond pulmonary function, improving sinonasal symptoms and emotional well-being.

  • #pediatrics
  • #pulmonology

Like

Save

Share